|
|||||
|
|
Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors |
|
| Authors: | Monica Ter‐Minassian Sui Zhang Nichole V. Brooks Lauren K. Brais Jennifer A. Chan David C. Christiani Xihong Lin Sylvie Gabriel Jérôme Dinet Matthew H. Kulke |
| Affiliation: | 1. Department of Medical Oncology, Dana‐Farber Cancer Institute, Boston, Massachusetts, USA;2. Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, USA;3. Kaiser Permanente, Rockville, Maryland, USA;4. Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA;5. Ipsen Pharma, Boulogne‐Billancourt, France |
| Abstract: | |
| Keywords: | Neuroendocrine tumors Somatostatin analogs Progression‐free survival Overall survival Landmark analysis |